pre-miRNA Information
pre-miRNA hsa-mir-452   
Genomic Coordinates chrX: 151959628 - 151959712
Synonyms MIRN452, hsa-mir-452, MIR452
Description Homo sapiens miR-452 stem-loop
Comment The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . The 5' end of the miRNA may be offset with respect to previous annotations.
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-452-5p
Sequence 14| AACUGUUUGCAGAGGAAACUGA |35
Evidence Experimental
Experiments Cloned
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol MMP2   
Synonyms CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1
Description matrix metallopeptidase 2
Transcript NM_001127891   
Other Transcripts NM_004530   
Expression
Putative miRNA Targets on MMP2
3'UTR of MMP2
(miRNA target sites are highlighted)
>MMP2|NM_001127891|3'UTR
   1 GCTGGCCCTGGCTCCCACAGGCCCTTCCTCTCCACTGCCTTCGATACACCGGGCCTGGAGAACTAGAGAAGGACCCGGAG
  81 GGGCCTGGCAGCCGTGCCTTCAGCTCTACAGCTAATCAGCATTCTCACTCCTACCTGGTAATTTAAGATTCCAGAGAGTG
 161 GCTCCTCCCGGTGCCCAAGAATAGATGCTGACTGTACTCCTCCCAGGCGCCCCTTCCCCCTCCAATCCCACCAACCCTCA
 241 GAGCCACCCCTAAAGAGATACTTTGATATTTTCAACGCAGCCCTGCTTTGGGCTGCCCTGGTGCTGCCACACTTCAGGCT
 321 CTTCTCCTTTCACAACCTTCTGTGGCTCACAGAACCCTTGGAGCCAATGGAGACTGTCTCAAGAGGGCACTGGTGGCCCG
 401 ACAGCCTGGCACAGGGCAGTGGGACAGGGCATGGCCAGGTGGCCACTCCAGACCCCTGGCTTTTCACTGCTGGCTGCCTT
 481 AGAACCTTTCTTACATTAGCAGTTTGCTTTGTATGCACTTTGTTTTTTTCTTTGGGTCTTGTTTTTTTTTTCCACTTAGA
 561 AATTGCATTTCCTGACAGAAGGACTCAGGTTGTCTGAAGTCACTGCACAGTGCATCTCAGCCCACATAGTGATGGTTCCC
 641 CTGTTCACTCTACTTAGCATGTCCCTACCGAGTCTCTTCTCCACTGGATGGAGGAAAACCAAGCCGTGGCTTCCCGCTCA
 721 GCCCTCCCTGCCCCTCCCTTCAACCATTCCCCATGGGAAATGTCAACAAGTATGAATAAAGACACCTACTGAGTGGCCGT
 801 GTTTGCCATCTGTTTTAGCAGAGCCTAGACAAGGGCCACAGACCCAGCCAGAAGCGGAAACTTAAAAAGTCCGAATCTCT
 881 GCTCCCTGCAGGGCACAGGTGATGGTGTCTGCTGGAAAGGTCAGAGCTTCCAAAGTAAACAGCAAGAGAACCTCAGGGAG
 961 AGTAAGCTCTAGTCCCTCTGTCCTGTAGAAAGAGCCCTGAAGAATCAGCAATTTTGTTGCTTTATTGTGGCATCTGTTCG
1041 AGGTTTGCTTCCTCTTTAAGTCTGTTTCTTCATTAGCAATCATATCAGTTTTAATGCTACTACTAACAATGAACAGTAAC
1121 AATAATATCCCCCTCAATTAATAGAGTGCTTTCTATGTGCAAGGCACTTTTCACGTGTCACCTATTTTAACCTTTCCAAC
1201 CACATAAATAAAAAAGGCCATTATTAGTTGAATCTTATTGATGAAGAGAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agUCAAAGGAGACGUUUGUCaa 5'
            || ||||   |:||||||  
Target 5' agAGCTTCCAAAGTAAACAGca 3'
923 - 944 144.00 -12.30
2
miRNA  3' agUCAAAG----GA-GACG-------UUUGUCAa 5'
            |||||:    || || |       :|||||| 
Target 5' tcAGTTTTAATGCTACTACTAACAATGAACAGTa 3'
1085 - 1118 130.00 -12.31
3
miRNA  3' agucAAAGGAGACGUUUGUCAa 5'
              ||||:|   : |:|||| 
Target 5' aaccTTTCTTACATTAGCAGTt 3'
483 - 504 110.00 -9.10
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
887103 44 ClinVar
319770 52 ClinVar
887104 94 ClinVar
887105 112 ClinVar
319771 133 ClinVar
319772 160 ClinVar
319773 171 ClinVar
888371 184 ClinVar
319774 213 ClinVar
319775 229 ClinVar
888372 251 ClinVar
319776 261 ClinVar
888373 278 ClinVar
319777 401 ClinVar
319778 454 ClinVar
319779 499 ClinVar
885266 506 ClinVar
885267 524 ClinVar
319780 542 ClinVar
319781 628 ClinVar
885268 643 ClinVar
319782 670 ClinVar
886161 800 ClinVar
319783 854 ClinVar
319784 873 ClinVar
319785 931 ClinVar
886162 1013 ClinVar
886163 1030 ClinVar
886164 1049 ClinVar
319786 1063 ClinVar
319787 1205 ClinVar
887176 1205 ClinVar
COSN30106276 2 COSMIC
COSN30184265 9 COSMIC
COSN30187484 16 COSMIC
COSN30497500 16 COSMIC
COSN31508931 25 COSMIC
COSN31554863 43 COSMIC
COSN26984808 47 COSMIC
COSN31501613 49 COSMIC
COSN31555242 51 COSMIC
COSN13676487 52 COSMIC
COSN30694018 58 COSMIC
COSN31602003 61 COSMIC
COSN28869718 78 COSMIC
COSN30190985 82 COSMIC
COSN30188004 91 COSMIC
COSN31603676 95 COSMIC
COSN30177778 98 COSMIC
COSN31524237 103 COSMIC
COSN31560738 139 COSMIC
COSN31576920 249 COSMIC
COSN28753856 261 COSMIC
COSN21468763 424 COSMIC
COSN26648295 470 COSMIC
COSN7261079 502 COSMIC
COSN31520596 508 COSMIC
COSN28661609 542 COSMIC
COSN29534527 552 COSMIC
COSN25804902 651 COSMIC
COSN25304299 916 COSMIC
COSN32056276 1085 COSMIC
COSN24157724 1237 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs766093882 4 dbSNP
rs776631548 6 dbSNP
rs759388881 9 dbSNP
rs764880330 14 dbSNP
rs1324274455 19 dbSNP
rs964089006 24 dbSNP
rs752682273 33 dbSNP
rs368916369 35 dbSNP
rs369685795 43 dbSNP
rs751617004 44 dbSNP
rs757511901 45 dbSNP
rs781389911 46 dbSNP
rs746291867 48 dbSNP
rs1389948912 49 dbSNP
rs756516690 51 dbSNP
rs200211639 52 dbSNP
rs1422059945 57 dbSNP
rs1026962459 65 dbSNP
rs1315810930 67 dbSNP
rs1246994472 68 dbSNP
rs952803075 72 dbSNP
rs1466767564 77 dbSNP
rs760604174 77 dbSNP
rs1362297330 90 dbSNP
rs112159982 94 dbSNP
rs1319975418 95 dbSNP
rs563901621 95 dbSNP
rs1270603884 99 dbSNP
rs528402680 109 dbSNP
rs111489165 112 dbSNP
rs1275672282 120 dbSNP
rs961976369 125 dbSNP
rs55926431 133 dbSNP
rs1259293972 140 dbSNP
rs1446036097 144 dbSNP
rs1448145280 146 dbSNP
rs1356851662 148 dbSNP
rs1168771849 157 dbSNP
rs17860019 160 dbSNP
rs138597641 162 dbSNP
rs36115725 166 dbSNP
rs1180050078 167 dbSNP
rs947778867 169 dbSNP
rs1045236326 170 dbSNP
rs41280909 171 dbSNP
rs111371964 184 dbSNP
rs746687095 185 dbSNP
rs1452227533 188 dbSNP
rs773355464 193 dbSNP
rs1393930096 197 dbSNP
rs1052145936 200 dbSNP
rs1380785935 209 dbSNP
rs369694784 210 dbSNP
rs1156558619 212 dbSNP
rs147506379 213 dbSNP
rs776941141 218 dbSNP
rs1041202485 222 dbSNP
rs556071860 224 dbSNP
rs1337574857 226 dbSNP
rs886052126 229 dbSNP
rs1241049018 231 dbSNP
rs567900496 232 dbSNP
rs1450493146 234 dbSNP
rs1296973970 244 dbSNP
rs1441882827 249 dbSNP
rs746546784 250 dbSNP
rs776083935 251 dbSNP
rs7201 261 dbSNP
rs114011630 265 dbSNP
rs1259330584 274 dbSNP
rs1015600178 277 dbSNP
rs185162550 278 dbSNP
rs189316191 296 dbSNP
rs1799839 299 dbSNP
rs1259333685 305 dbSNP
rs557770088 311 dbSNP
rs1484812469 318 dbSNP
rs1279887708 322 dbSNP
rs1216518667 324 dbSNP
rs1318837460 337 dbSNP
rs180797471 338 dbSNP
rs1356720550 342 dbSNP
rs1295493403 346 dbSNP
rs540184171 356 dbSNP
rs1182416797 362 dbSNP
rs1374406432 369 dbSNP
rs1251205336 373 dbSNP
rs1298451054 375 dbSNP
rs1420798529 379 dbSNP
rs1454860269 384 dbSNP
rs1179463532 388 dbSNP
rs561637958 388 dbSNP
rs1157799549 397 dbSNP
rs1405871594 400 dbSNP
rs17860021 401 dbSNP
rs980659415 411 dbSNP
rs1474766435 414 dbSNP
rs1257017916 416 dbSNP
rs1187299791 426 dbSNP
rs369497688 434 dbSNP
rs1486999779 437 dbSNP
rs925020874 440 dbSNP
rs1177463537 448 dbSNP
rs562314074 454 dbSNP
rs1275609983 459 dbSNP
rs1468345231 474 dbSNP
rs1231787567 483 dbSNP
rs1336129205 494 dbSNP
rs1374781825 496 dbSNP
rs886052127 499 dbSNP
rs533480220 503 dbSNP
rs780960741 506 dbSNP
rs141779983 524 dbSNP
rs552111250 540 dbSNP
rs1368786329 542 dbSNP
rs1396525746 542 dbSNP
rs886052128 542 dbSNP
rs1305406580 544 dbSNP
rs1162733774 559 dbSNP
rs1799840 566 dbSNP
rs1460692752 568 dbSNP
rs760947188 571 dbSNP
rs1335579812 579 dbSNP
rs1409446962 590 dbSNP
rs1799818 595 dbSNP
rs186661803 597 dbSNP
rs1224450872 612 dbSNP
rs944245679 613 dbSNP
rs1430516682 617 dbSNP
rs17860023 621 dbSNP
rs886052129 628 dbSNP
rs1320928466 629 dbSNP
rs182135957 632 dbSNP
rs1468979835 636 dbSNP
rs900111888 642 dbSNP
rs771470902 643 dbSNP
rs1212335786 648 dbSNP
rs1048597641 660 dbSNP
rs17860024 670 dbSNP
rs571352875 671 dbSNP
rs1063976 675 dbSNP
rs1063977 677 dbSNP
rs1063978 680 dbSNP
rs1294427125 683 dbSNP
rs1015519826 687 dbSNP
rs1194014252 689 dbSNP
rs15142 690 dbSNP
rs895840362 695 dbSNP
rs1014233455 701 dbSNP
rs1058373 704 dbSNP
rs1024835623 706 dbSNP
rs969314564 707 dbSNP
rs980973810 717 dbSNP
rs1299601822 721 dbSNP
rs1460286591 722 dbSNP
rs1032182824 725 dbSNP
rs111803078 727 dbSNP
rs1170042812 732 dbSNP
rs1431774969 739 dbSNP
rs1396948599 742 dbSNP
rs1191894326 745 dbSNP
rs1468427270 746 dbSNP
rs1251879421 747 dbSNP
rs150600148 754 dbSNP
rs913675335 764 dbSNP
rs571732457 767 dbSNP
rs943669977 768 dbSNP
rs1234533051 783 dbSNP
rs866009096 785 dbSNP
rs976447594 799 dbSNP
rs112093666 800 dbSNP
rs868112480 801 dbSNP
rs1389417456 802 dbSNP
rs1296980365 809 dbSNP
rs932922938 810 dbSNP
rs1049009221 827 dbSNP
rs35646586 829 dbSNP
rs1435561636 830 dbSNP
rs888637547 836 dbSNP
rs539550309 854 dbSNP
rs775603988 855 dbSNP
rs895933919 856 dbSNP
rs373038333 857 dbSNP
rs753993450 865 dbSNP
rs1417897572 867 dbSNP
rs140455191 873 dbSNP
rs533551891 874 dbSNP
rs147262155 878 dbSNP
rs867091151 885 dbSNP
rs1308784513 888 dbSNP
rs1224553256 896 dbSNP
rs1277763888 898 dbSNP
rs1209464175 900 dbSNP
rs760876032 906 dbSNP
rs1350801537 907 dbSNP
rs1280820186 909 dbSNP
rs1236760956 910 dbSNP
rs1335163320 913 dbSNP
rs957875972 921 dbSNP
rs886052130 931 dbSNP
rs988406672 944 dbSNP
rs1357550152 948 dbSNP
rs575579593 953 dbSNP
rs1250742212 959 dbSNP
rs1020707310 962 dbSNP
rs1311317418 963 dbSNP
rs1413941472 964 dbSNP
rs1385722174 969 dbSNP
rs1490484651 970 dbSNP
rs1452255315 974 dbSNP
rs965165054 975 dbSNP
rs1266492955 976 dbSNP
rs1490108968 980 dbSNP
rs1476402204 983 dbSNP
rs1254907192 984 dbSNP
rs976377225 996 dbSNP
rs1186737829 1002 dbSNP
rs920941492 1009 dbSNP
rs1447267044 1013 dbSNP
rs1202925417 1014 dbSNP
rs763847728 1020 dbSNP
rs932870161 1033 dbSNP
rs764052225 1040 dbSNP
rs573620043 1041 dbSNP
rs1420432387 1042 dbSNP
rs910150010 1043 dbSNP
rs185917725 1048 dbSNP
rs776889997 1049 dbSNP
rs1037196323 1052 dbSNP
rs1168379520 1061 dbSNP
rs2052264 1063 dbSNP
rs1463509435 1068 dbSNP
rs950144654 1071 dbSNP
rs1163094534 1072 dbSNP
rs1475537367 1080 dbSNP
rs1044346008 1081 dbSNP
rs1425827999 1082 dbSNP
rs371723438 1082 dbSNP
rs1190328840 1083 dbSNP
rs1305425282 1085 dbSNP
rs1364103295 1086 dbSNP
rs905882150 1088 dbSNP
rs1404682106 1092 dbSNP
rs1289113410 1096 dbSNP
rs1332649522 1097 dbSNP
rs191126061 1098 dbSNP
rs1214945911 1100 dbSNP
rs1340249011 1117 dbSNP
rs1380067810 1122 dbSNP
rs1225282855 1129 dbSNP
rs1364502016 1130 dbSNP
rs1000626247 1131 dbSNP
rs1053693844 1133 dbSNP
rs1393005922 1148 dbSNP
rs1360146197 1150 dbSNP
rs1323233810 1155 dbSNP
rs1410896695 1165 dbSNP
rs765405697 1166 dbSNP
rs1165824256 1175 dbSNP
rs183272313 1176 dbSNP
rs750227380 1177 dbSNP
rs1289454815 1182 dbSNP
rs1195020600 1189 dbSNP
rs1009399648 1193 dbSNP
rs534203573 1199 dbSNP
rs758075499 1205 dbSNP
rs1283937268 1211 dbSNP
rs1270668285 1217 dbSNP
rs997950336 1221 dbSNP
rs1341788648 1223 dbSNP
rs1304246017 1224 dbSNP
rs1236596524 1227 dbSNP
rs1216210441 1231 dbSNP
rs1242954040 1239 dbSNP
rs1274803151 1243 dbSNP
rs1356610682 1250 dbSNP
rs1443339144 1250 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions doner
Disease MIMAT0001635
Location of target site 3'UTR
Tools used in this research MicroCosm , TargetScan
Original Description (Extracted from the article) ... "Transfecting in an inhibitor of miR-452 resulted in elevated expression of MMP12 transcripts ...

- Graff JW; Powers LS; Dickson AM; Kim J; et al., 2012, PloS one.

Article - Graff JW; Powers LS; Dickson AM; Kim J; et al.
- PloS one, 2012
Human alveolar macrophages are critical components of the innate immune system. Cigarette smoking-induced changes in alveolar macrophage gene expression are linked to reduced resistance to pulmonary infections and to the development of emphysema/COPD. We hypothesized that microRNAs (miRNAs) could control, in part, the unique messenger RNA (mRNA) expression profiles found in alveolar macrophages of cigarette smokers. Activation of macrophages with different stimuli in vitro leads to a diverse range of M1 (inflammatory) and M2 (anti-inflammatory) polarized phenotypes that are thought to mimic activated macrophages in distinct tissue environments. Microarray mRNA data indicated that smoking promoted an "inverse" M1 mRNA expression program, defined by decreased expression of M1-induced transcripts and increased expression of M1-repressed transcripts with few changes in M2-regulated transcripts. RT-PCR arrays identified altered expression of many miRNAs in alveolar macrophages of smokers and a decrease in global miRNA abundance. Stratification of human subjects suggested that the magnitude of the global decrease in miRNA abundance was associated with smoking history. We found that many of the miRNAs with reduced expression in alveolar macrophages of smokers were predicted to target mRNAs upregulated in alveolar macrophages of smokers. For example, miR-452 is predicted to target the transcript encoding MMP12, an important effector of smoking-related diseases. Experimental antagonism of miR-452 in differentiated monocytic cells resulted in increased expression of MMP12. The comprehensive mRNA and miRNA expression profiles described here provide insight into gene expression regulation that may underlie the adverse effects cigarette smoking has on alveolar macrophages.
LinkOut: [PMID: 22952876]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE21687 Ependynoma primary tumors 0.583 2.2e-7 0.389 7.4e-4 64 Click to see details
GSE42095 Differentiated embryonic stem cells 0.731 3.7e-5 0.678 1.9e-4 23 Click to see details
GSE21032 Prostate cancer 0.353 5.3e-4 0.353 5.3e-4 83 Click to see details
GSE38974 Chronic obstructive pulmonary disease 0.615 5.3e-4 0.492 6.2e-3 25 Click to see details
GSE28544 Breast cancer -0.602 9.3e-4 -0.635 4.3e-4 24 Click to see details
GSE27834 Pluripotent stem cells 0.42 5.3e-2 0.429 4.9e-2 16 Click to see details
GSE19350 CNS germ cell tumors 0.456 6.8e-2 0.315 1.6e-1 12 Click to see details
GSE35602 Colorectal cancer stromal tissue 0.281 8.7e-2 0.265 1.0e-1 25 Click to see details
GSE17498 Multiple myeloma 0.215 9.1e-2 0.191 1.2e-1 40 Click to see details
GSE19536 Breast cancer 0.102 1.6e-1 0.119 1.2e-1 100 Click to see details
GSE21849 B cell lymphoma 0.189 1.6e-1 0.548 1.0e-3 29 Click to see details
GSE19783 ER+ ER+ breast cancer 0.23 1.6e-1 0.223 1.7e-1 20 Click to see details
GSE14794 Lymphoblastoid cells 0.093 1.9e-1 0.117 1.4e-1 90 Click to see details
GSE28260 Renal cortex and medulla -0.196 2.6e-1 -0.203 2.5e-1 13 Click to see details
GSE26953 Aortic valvular endothelial cells -0.123 2.8e-1 -0.147 2.5e-1 24 Click to see details
GSE38226 Liver fibrosis -0.121 3.0e-1 -0.087 3.5e-1 21 Click to see details
GSE17306 Multiple myeloma -0.072 3.1e-1 -0.020 4.5e-1 49 Click to see details
GSE32688 Pancreatic cancer -0.066 3.6e-1 0.094 3.0e-1 32 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis 0.084 3.6e-1 -0.164 2.4e-1 20 Click to see details
GSE19783 ER- ER- breast cancer 0.004 4.9e-1 0.020 4.3e-1 79 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
STAD -0.576 0 -0.456 0 32 Click to see details
KICH 0.382 0.03 0.424 0.02 25 Click to see details
BRCA 0.201 0.03 0.173 0.06 84 Click to see details
LIHC 0.213 0.07 0.219 0.07 49 Click to see details
ESCA -0.463 0.08 -0.400 0.11 11 Click to see details
KIRC 0.167 0.09 0.133 0.14 68 Click to see details
CHOL -0.49 0.09 -0.500 0.09 9 Click to see details
PAAD 0.681 0.16 0.800 0.1 4 Click to see details
UCEC -0.22 0.18 -0.160 0.26 19 Click to see details
COAD 0.311 0.23 0.738 0.02 8 Click to see details
LUAD 0.185 0.28 0.133 0.34 12 Click to see details
KIRP 0.103 0.29 0.097 0.3 32 Click to see details
LUSC -0.085 0.31 -0.077 0.32 38 Click to see details
THCA 0.059 0.33 0.107 0.21 59 Click to see details
PCPG 0.505 0.33 0.500 0.33 3 Click to see details
HNSC -0.065 0.34 -0.207 0.09 42 Click to see details
PRAD 0.041 0.39 0.103 0.24 50 Click to see details
CESC 0.083 0.47 0.500 0.33 3 Click to see details
BLCA 0.014 0.48 -0.115 0.32 18 Click to see details
BLCA 0.014 0.48 -0.115 0.32 18 Click to see details
BLCA 0.014 0.48 -0.115 0.32 18 Click to see details
70 hsa-miR-452-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT053449 BAG4 BCL2 associated athanogene 4 1 1
MIRT053450 ITGA9 integrin subunit alpha 9 1 1
MIRT053451 RAB3B RAB3B, member RAS oncogene family 1 1
MIRT053452 CDK6 cyclin dependent kinase 6 1 1
MIRT053453 TBK1 TANK binding kinase 1 1 1
MIRT053454 RHOU ras homolog family member U 1 1
MIRT053455 NOTCH2NL notch 2 N-terminal like 1 1
MIRT053456 TNF tumor necrosis factor 1 1
MIRT053457 IL3 interleukin 3 1 1
MIRT053458 TNFAIP8 TNF alpha induced protein 8 1 1
MIRT053459 CASD1 CAS1 domain containing 1 1 1
MIRT053460 SMAD4 SMAD family member 4 1 1
MIRT053522 DPYSL2 dihydropyrimidinase like 2 2 1
MIRT053523 KRAS KRAS proto-oncogene, GTPase 2 1
MIRT053787 MMP2 matrix metallopeptidase 2 2 1
MIRT053788 TM7SF4 dendrocyte expressed seven transmembrane protein 2 1
MIRT054841 THRB thyroid hormone receptor beta 3 1
MIRT076091 ADORA2B adenosine A2b receptor 2 2
MIRT133747 SKI SKI proto-oncogene 2 2
MIRT437780 BMI1 BMI1 proto-oncogene, polycomb ring finger 1 1
MIRT437781 LEF1 lymphoid enhancer binding factor 1 1 1
MIRT437782 TCF4 transcription factor 4 1 1
MIRT438015 CDKN1B cyclin dependent kinase inhibitor 1B 5 3
MIRT486626 PDK3 pyruvate dehydrogenase kinase 3 2 2
MIRT493350 LAMC1 laminin subunit gamma 1 2 8
MIRT495000 TSSC1 EARP complex and GARP complex interacting protein 1 2 2
MIRT497724 CYP1A1 cytochrome P450 family 1 subfamily A member 1 2 2
MIRT498197 AKR1B10 aldo-keto reductase family 1 member B10 2 2
MIRT500265 ZNF788 zinc finger family member 788 2 6
MIRT500608 UBE2D1 ubiquitin conjugating enzyme E2 D1 2 6
MIRT507531 DSTN destrin, actin depolymerizing factor 2 2
MIRT513420 RTP4 receptor transporter protein 4 2 2
MIRT515388 RPL7 ribosomal protein L7 2 2
MIRT516404 FAM26E calcium homeostasis modulator family member 5 2 2
MIRT531390 TXNDC16 thioredoxin domain containing 16 2 2
MIRT533161 WNK1 WNK lysine deficient protein kinase 1 2 2
MIRT533983 TADA2A transcriptional adaptor 2A 2 2
MIRT544365 EGLN1 egl-9 family hypoxia inducible factor 1 2 2
MIRT545406 KIAA1715 lunapark, ER junction formation factor 2 2
MIRT551367 EPM2AIP1 EPM2A interacting protein 1 2 2
MIRT556491 LIPA lipase A, lysosomal acid type 2 2
MIRT559336 ATP5G3 ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) 2 2
MIRT561668 REST RE1 silencing transcription factor 2 2
MIRT565353 TMED2 transmembrane p24 trafficking protein 2 2 2
MIRT565366 TMCC1 transmembrane and coiled-coil domain family 1 2 2
MIRT571405 MED4 mediator complex subunit 4 2 2
MIRT574476 RPS16 ribosomal protein S16 2 2
MIRT609702 GFRA1 GDNF family receptor alpha 1 2 2
MIRT611081 ZNF621 zinc finger protein 621 2 2
MIRT613238 CCDC39 coiled-coil domain containing 39 2 2
MIRT614618 MVK mevalonate kinase 2 2
MIRT615351 SMU1 DNA replication regulator and spliceosomal factor 2 4
MIRT620013 CCDC137 coiled-coil domain containing 137 2 2
MIRT623722 HACE1 HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 2 2
MIRT637022 CLASP1 cytoplasmic linker associated protein 1 2 2
MIRT637353 PIGP phosphatidylinositol glycan anchor biosynthesis class P 2 2
MIRT638050 SHPK sedoheptulokinase 2 2
MIRT657131 ITPRIPL1 inositol 1,4,5-trisphosphate receptor interacting protein-like 1 2 2
MIRT657453 HEYL hes related family bHLH transcription factor with YRPW motif-like 2 2
MIRT666586 RHOBTB3 Rho related BTB domain containing 3 2 2
MIRT701745 MTDH metadherin 2 2
MIRT702145 MAP3K1 mitogen-activated protein kinase kinase kinase 1 2 2
MIRT709155 ZNF799 zinc finger protein 799 2 2
MIRT711051 IRS1 insulin receptor substrate 1 2 2
MIRT716104 HARS histidyl-tRNA synthetase 2 2
MIRT717265 BMPR2 bone morphogenetic protein receptor type 2 2 2
MIRT721687 MRPL19 mitochondrial ribosomal protein L19 2 2
MIRT722340 BEND6 BEN domain containing 6 2 2
MIRT732741 VEGFA vascular endothelial growth factor A 3 0
MIRT734714 EZR ezrin 2 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-452 Formaldehyde NULL 712 Microarray Human lung epithelial cells (A549) 21147603 2011 down-regulated
miR-452 Phenethyl isothiocyanate(PEITC) NULL 16741 Microarray neonatal mice liver 20145010 2010 up-regulated
miR-452 Tert-butyl hydroperoxide (t-BHP) NULL 6410 Microarray mouse auditory cells 20510889 2010 down-regulated
miR-452 Reversine NULL 210332 Microarray C2C12 myoblast cells 24513286 2014 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-452 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-452 Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (A2780CP20)
hsa-mir-452 Cisplatin 5460033 NSC119875 approved resistant cell line (CP20)
hsa-mir-452 Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-mir-452 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-452-5p (11r,15s,17s)-17-methyl-14,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3,5,7-tetraene-2,9-dione 54611663 NSC722392 resistant
hsa-miR-452-5p (2e)-2-hydroxyimino-4-(3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)-4-oxo-n-(2,4,5-trichlorophenyl)butanamide 6399319 NSC635544 resistant
hsa-miR-452-5p (2Z,6Z)-2,6-bis[[3-[(dimethylamino)methyl]-4-hydroxyphenyl]methylidene]cyclohexan-1-one 6067712 NSC683834 sensitive
hsa-miR-452-5p (3e)-3-[(2-chloro-1-phenylindol-3-yl)methylidene]-5-methoxy-6-methyl-1h-indol-2-one 5471471 NSC711611 sensitive
hsa-miR-452-5p (3e)-5-methoxy-3-[(6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-1h-indol-2-one 5471411 NSC711066 sensitive
hsa-miR-452-5p (4aR,9aR)-9-(4-methylphenyl)sulfonyl-3,4,4a,9a-tetrahydrocarbazole 372866 NSC648556 sensitive
hsa-miR-452-5p (4e)-4-(3h-1,3-benzothiazol-2-ylidene)-1-[4-(difluoromethylsulfanyl)phenyl]-5-iminopyrrolidin-2-one 135543874 NSC744116 sensitive
hsa-miR-452-5p (4e)-4-(3h-1,3-benzothiazol-2-ylidene)-5-imino-1-(3-methoxyphenyl)pyrrolidin-2-one 135892287 NSC744115 sensitive
hsa-miR-452-5p (4S,9aR)-4-(4-fluoroanilino)-9-(4-hydroxy-3,5-dimethoxyphenyl)-6,7-dimethoxy-3a,4,9,9a-tetrahydro-3H-benzo[f][2]benzofuran-1-one 369962 NSC642329 sensitive
hsa-miR-452-5p (4z)-n-[(2-chlorobenzylidene)amino]-4-(dimethylaminohydrazono)-5-methyl-pyrazole-3-carboxamide 135545659 NSC131257 sensitive
hsa-miR-452-5p (5s,8ar)-5-[(1-benzylpiperidin-4-yl)amino]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one;hydrochloride 374331 NSC651855 sensitive
hsa-miR-452-5p (8e)-2-amino-4-(3,4-dimethoxyphenyl)-8-[(3,4-dimethoxyphenyl)methylidene]-5-methyl-6,7-dihydro-5h-quinoline-3-carbonitrile NSC690754 sensitive
hsa-miR-452-5p (8R,9S,10R,13S,14S,16E)-10,13-dimethyl-16-[[3-(2-morpholin-4-ylethoxy)phenyl]methylidene]-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,17-dione 24205793 NSC736753 sensitive
hsa-miR-452-5p (e)-1-(benzenesulfonyl)-3-(2-phenyl-1h-indol-3-yl)prop-2-en-1-one 54613416 NSC749193 sensitive
hsa-miR-452-5p (E)-1-[4-(quinazolin-4-ylamino)phenyl]-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 155816064 NSC760015 sensitive
hsa-miR-452-5p (E)-2-(3,4-dihydroxybenzoyl)-3-(1H-indol-3-yl)prop-2-enenitrile 5329275 NSC650934 sensitive
hsa-miR-452-5p (Z)-[5-(4-carboxy-N-methylanilino)-2,4-dinitrophenoxy]imino-(dimethylamino)-oxidoazanium 11154356 NSC731703 resistant
hsa-miR-452-5p [(1r,2r,3ar,4s,5s,6e,9s,10r,11s,13r,13as)-2,4,13-triacetyloxy-1-benzoyloxy-3a,10-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-11-(2-methylpropoxy)-3,4,5,9,10,11,13,13a-octahydro-1h-cyclopenta[12]annul 5469445 NSC688235 sensitive
hsa-miR-452-5p [(1r,2r,3r,4r,6r,8s,9e,12s,13s,14r,15s)-3,4,6,12,13-pentaacetyloxy-4,8,11,11-tetramethyl-14-(2-methylpropoxy)-7,18-dioxo-19-oxatricyclo[13.4.0.02,6]nonadec-9-en-15-yl] benzoate 5469441 NSC688228 sensitive
hsa-miR-452-5p [(1R,2S,10S,13S,14R)-7-(4-fluorophenyl)-10,14-dimethyl-6,7,9-triazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-4(8),5,19-trien-17-yl] acetate 392371 NSC692655 sensitive
hsa-miR-452-5p [(1S,16E,24E,26E,28Z)-1-hydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-18-yl] 3-(diethylamino)propanoate; 5386305 NSC606699 sensitive
hsa-miR-452-5p [(3s,8r,10r,13s,17e)-10,13-dimethyl-17-(phenylcarbamoyloxyimino)-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] n-phenylcarbamate 9569960 NSC629229 sensitive
hsa-miR-452-5p [(3s,8r,9s,10r,13s,14s,16e,17e)-16-[(3,4-dimethoxyphenyl)methylidene]-17-hydroxyimino-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate 9572442 NSC716258 sensitive
hsa-miR-452-5p [2-(12,14-dioxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)-3-hydroxy-6-(hydroxymethyl)-5-methoxyoxan-4-yl] 2,6-diaminohexanoate;hydrochloride 24203046 NSC726578 resistant
hsa-miR-452-5p 1'-hydroxy-2'-(naphthalene-1-carbonyl)-1'-naphthalen-1-ylspiro[1,3-dihydro-1-benzazepine-4,4'-cyclohexane]-2,5-dione NSC682763 sensitive
hsa-miR-452-5p 1-(1-naphthylmethylene)-4-(1-naphthyl)semicarbazide 5859414 NSC680931 sensitive
hsa-miR-452-5p 11-(4-nitrophenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608965 NSC697748 resistant
hsa-miR-452-5p 13-methoxy-6-methyl-2-nitro-6,9,17-triazatetracyclo[8.7.1.05,18.011,16]octadeca-1,3,5(18),10,12,14,16-heptaene 438699 NSC658995 resistant
hsa-miR-452-5p 1h-benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9ci) NSC659162 sensitive
hsa-miR-452-5p 2-((5-methyl-3-isoxazolyl)amino)-4-((5-methyl-3-isoxazolyl)imino)-1(4h)-naphthalenone 373420 NSC649750 resistant
hsa-miR-452-5p 2-(1-hydroxyethyl)thieno[3,2-f][1]benzothiole-4,8-dione 391375 NSC690432 resistant
hsa-miR-452-5p 2-(2-amino-6-phenylpyrimidin-4-yl)-4-methylphenol 386504 NSC678879 sensitive
hsa-miR-452-5p 2-[(e)-[6-(3,6-dimethoxy-2-nitrophenyl)-2-propylimidazo[2,1-b][1,3]thiazol-5-yl]methylideneamino]guanidine;hydrochloride 9572654 NSC723548 sensitive
hsa-miR-452-5p 2-[[(1s,5s,8z,12s,20s)-13-phenoxycarbonyl-21-oxa-13-azapentacyclo[10.9.0.01,20.05,20.014,19]henicosa-8,14,16,18-tetraen-6,10-diyn-5-yl]oxy]acetic acid 54604782 NSC677586 resistant
hsa-miR-452-5p 2-[[(3s,8s,9s,10r,11s,13s,14s,16s,17r)-3,11-dihydroxy-17-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-16-yl]oxy]-6-methy 392623 NSC693185 sensitive
hsa-miR-452-5p 2-[4-[5-(3,4-dimethoxyphenyl)imidazol-1-yl]phenyl]-5,7-dimethoxy-1,3-benzothiazole 60147635 NSC751902 sensitive
hsa-miR-452-5p 2-acetyl-1,2-dihydroellipticine 376328 NSC657149 resistant
hsa-miR-452-5p 2,3-dehydrosarcovagine d 54612860 NSC748913 sensitive
hsa-miR-452-5p 2,3-dimethoxyindolo[2,1-a]isoquinolin-7-ium-12-one 498408 NSC627787 resistant
hsa-miR-452-5p 2,3,5-triphenyl-1,3-selenazol-3-ium-4-olate 363056 NSC627605 resistant
hsa-miR-452-5p 2,5,11-trimethyl-9-phenoxy-6h-pyrido[4,3-b]carbazol-2-ium;acetate 10431819 NSC650269 sensitive
hsa-miR-452-5p 2,7-bis(methoxycarbonylmethyl)-10-methylphenothiazine 384444 NSC674225 sensitive
hsa-miR-452-5p 3-(3,5-dibromo-4-methoxyphenyl)-2-(3-pyridinyl)acrylonitrile 5467796 NSC659319 sensitive
hsa-miR-452-5p 3-(3,5-dichlorophenyl)-2-(2-pyridinyl)acrylonitrile 5467799 NSC659323 sensitive
hsa-miR-452-5p 3-(4-methoxyphenyl)-4-methyl-8-pyrrolidin-1-yl-8H-thieno[2,3-b]pyrrolizin-4-ium;iodide 388538 NSC683518 sensitive
hsa-miR-452-5p 3-(4-methoxyphenyl)-5,5,5-triphenyl-4,5-dihydro-1,2,5lambda(5)-oxazaphosphole NSC304610 sensitive
hsa-miR-452-5p 3-(benzenesulfonyl)-7-benzyl-2-methoxy-5,6-dihydropyrazolo[3,4-h]quinoline 54613023 NSC750762 sensitive
hsa-miR-452-5p 3-[(2,3-dimethoxyphenyl)methyl]-7,8-dimethoxy-5-methylsulfanyl-2,5-dihydro-1H-3-benzazepin-4-one 359177 NSC619859 sensitive
hsa-miR-452-5p 3-[2-(1h-indol-3-yl)-2-oxoethyl]quinoxalin-2(1h)-one 400273 NSC711806 sensitive
hsa-miR-452-5p 3-bromo-4-(2-(4-methoxyphenyl)ethynyl)furan-2(5h)-one 24204187 NSC730944 sensitive
hsa-miR-452-5p 3,5-dichloro-N-[4-[3-(3-chloro-4-methoxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]benzamide 142712058 NSC755465 sensitive
hsa-miR-452-5p 4-(2-(((6-bromo-1,3-benzodioxol-5-yl)methyl)amino)ethyl)phenol 290548 NSC154572 sensitive
hsa-miR-452-5p 4-(4-carbazol-9-ylbutanoylamino)-n-[5-[3-(dimethylamino)propylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide 406397 NSC724462 sensitive
hsa-miR-452-5p 4-(4-chlorophenyl)-N-(2-methoxyphenyl)-3-prop-2-enyl-1,3-thiazol-2-imine;hydrobromide 396119 NSC701666 sensitive
hsa-miR-452-5p 4-[(1-benzyl-4-chloro-2,5-dioxopyrrol-3-yl)amino]-N-(4-fluorophenyl)benzamide 1194957 NSC732830 sensitive
hsa-miR-452-5p 4-[(2z)-2-(5-oxooxolan-2-ylidene)ethoxy]chromen-2-one 24205379 NSC735331 resistant
hsa-miR-452-5p 4-[(4z)-5-oxo-4-[(4-phenoxyphenyl)methylidene]-2-phenylimidazol-1-yl]-n-(1,3-thiazol-2-yl)benzenesulfonamide 5472414 NSC718649 sensitive
hsa-miR-452-5p 4-[2-(5,6-dihydrobenzo[a]carbazol-11-yl)ethyl]morpholine 390894 NSC689069 sensitive
hsa-miR-452-5p 4-[4-(3-methoxyphenyl)piperazin-1-yl]-5H-pyrrolo[3,2-d]pyrimidine 155815900 NSC754824 sensitive
hsa-miR-452-5p 4-acetylspiro[1,3,5,6,7,8-hexahydrocyclopenta[b]naphthalene-2,2'-3,6,7,8-tetrahydro-1h-cyclopenta[g]naphthalene]-5'-one 382750 NSC670428 sensitive
hsa-miR-452-5p 4-benzyl-1-(2-chlorophenyl)-[1,2,4]triazolo[4,3-a]quinoxaline 46945878 NSC761676 sensitive
hsa-miR-452-5p 4-nitro-n-[(7s)-1,2,3-trihydroxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl]benzamide 391582 NSC691037 sensitive
hsa-miR-452-5p 4,4-diphenyl-2-(3,4,5-trimethoxyphenyl)-1,3-diazinane;hydrochloride 379863 NSC665001 sensitive
hsa-miR-452-5p 4,5-bis(4-methoxyphenyl)-1h-imidazol-2(5h)-one 231112 NSC26692 sensitive
hsa-miR-452-5p 4,5,15,16-tetraphenyl-10-(2,4,6-triphenylpyridin-1-ium-1-yl)-3,6,14,17-tetraoxa-23-azatricyclo[17.3.1.18,12]tetracosa-1(23),8(24),9,11,19,21-hexaen-24-olate 16129807 NSC674178 sensitive
hsa-miR-452-5p 5-(4-chlorophenyl)-n-(3,4,5-trimethoxyphenyl)-1h-pyrazol-4-amine 45028878 NSC744683 sensitive
hsa-miR-452-5p 5-[(E)-2-(5-ethyl-1-methylpyridin-1-ium-2-yl)ethenyl]quinolin-8-ol;iodide 135534376 NSC79543 sensitive
hsa-miR-452-5p 5-[2-(2,5-dimethoxyphenyl)ethynyl]-N-[2-(4-fluorophenyl)ethyl]-2-methoxybenzamide 403660 NSC718728 sensitive
hsa-miR-452-5p 5-[2-(2,5-dimethoxyphenyl)ethynyl]-N-hexyl-2-methoxybenzamide 403659 NSC718727 sensitive
hsa-miR-452-5p 5-[3-[(7-chloroquinolin-4-yl)amino]phenyl]-3-(3,4,5-trimethoxyphenyl)-3,4-dihydropyrazole-2-carbaldehyde 72374830 NSC762542 sensitive
hsa-miR-452-5p 5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-1H-indole-2-carboxamide 24205446 NSC735540 sensitive
hsa-miR-452-5p 5,11-dimethyl-1h-benzo[a]carbazole-1,4(11h)-dione 372651 NSC648148 sensitive
hsa-miR-452-5p 6-hydroxy-3,3,11,12-tetramethyl-pyrano[2,3-c]acridin-7-one 5465763 NSC660813 sensitive
hsa-miR-452-5p 8-(2,3-dimethoxyphenyl)-7-methyl-n-phenyl-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-6-amine 381363 NSC667903 sensitive
hsa-miR-452-5p 8-chloro-3-(naphthalen-1-ylamino)-5,5-dioxo-[1,2,4]triazolo[4,3-b][1,4,2]benzodithiazine-7-carbonitrile 406667 NSC724907 resistant
hsa-miR-452-5p 8-hydroxymanzamine a 5468481 NSC670852 sensitive
hsa-miR-452-5p Abiraterone 132971 NSC749226 approved sensitive
hsa-miR-452-5p Aminopyrimidine-f 406276 NSC724328 sensitive
hsa-miR-452-5p Ammonium trichlorotellurate NSC618654 sensitive
hsa-miR-452-5p Austocystin d 5470400 NSC700893 resistant
hsa-miR-452-5p Azure b bromide 13797451 NSC16166 resistant
hsa-miR-452-5p Blastmycin 245869 NSC58239 sensitive
hsa-miR-452-5p C8, carbonyl prodigiosine 135540857 NSC742417 sensitive
hsa-miR-452-5p Dimethyl 2,2'-(pyridine-2,6-diyldicarbonyl)bis(1-methylhydrazinecarbodithioate) 375401 NSC655072 sensitive
hsa-miR-452-5p Dromostanolone propionate 224004 NSC12198 sensitive
hsa-miR-452-5p Ethyl 2-[(2e)-2-[(4-chlorophenyl)methylidene]hydrazinyl]-5-phenyl-1h-pyrrole-3-carboxylate 45027953 NSC740252 sensitive
hsa-miR-452-5p Gsk718429a 44587530 NSC756188 sensitive
hsa-miR-452-5p Hexyl (e)-3-[(2s,4z)-2-(hydroxymethyl)-4-(4-methyl-3-propan-2-ylpentylidene)-5-oxooxolan-2-yl]prop-2-enoate 5471817 NSC714070 sensitive
hsa-miR-452-5p Hopeaphenol 495605 NSC661748 resistant
hsa-miR-452-5p Hydrazine sulfate 24842 NSC150014 sensitive
hsa-miR-452-5p Iejimalide a. 5473233 NSC724579 sensitive
hsa-miR-452-5p Indoline, 5-chloro-1,3,3-trimethyl-2-methylene- (8ci) 81308 NSC158263 sensitive
hsa-miR-452-5p Isatin dr 24204246 NSC731093 sensitive
hsa-miR-452-5p Itraconazole 55283 NSC754771 approved sensitive
hsa-miR-452-5p J-400634 385621 NSC676944 sensitive
hsa-miR-452-5p Kipca 4055 NSC4170 approved resistant
hsa-miR-452-5p L-lys-l-p-no2phe-l-ala-l-p-no2phenh2 386384 NSC678355 sensitive
hsa-miR-452-5p Ls-133613 365597 NSC633398 sensitive
hsa-miR-452-5p Ls-41225 57787 NSC664951 sensitive
hsa-miR-452-5p Ls-58067 379524 NSC664181 sensitive
hsa-miR-452-5p Ls-59969 380292 NSC665773 sensitive
hsa-miR-452-5p Mauve 407617 NSC7801 sensitive
hsa-miR-452-5p Methyl (2R,11bS)-2-[[(3R)-3-ethyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-3-sulfanylidene-2,5,6,11-tetrahydro-1H-indolizino[8,7-b]indole-11b-carboxylate 386808 NSC679516 sensitive
hsa-miR-452-5p N'-butyl-4-[2-[2-[4-(N'-butylcarbamimidoyl)phenoxy]ethylsulfanyl]ethoxy]benzenecarboximidamide;hydrochloride 54613223 NSC750501 sensitive
hsa-miR-452-5p N-(4-((4-anilino-1-benzyl-4-piperidinyl)ethynyl)-1-benzyl-4-piperidinyl)-n-phenylamine 379997 NSC665299 sensitive
hsa-miR-452-5p N-[(3S,10S,13S,17S)-17-[1-(dimethylamino)ethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]formamide 54612852 NSC748904 sensitive
hsa-miR-452-5p N-[(e)-[2-chloro-4-(dimethylamino)phenyl]methylideneamino]naphthalene-1-carboxamide 9568495 NSC115980 sensitive
hsa-miR-452-5p N-[(e)-[6-(2,5-dimethylanilino)-1-(4-hydroxyphenyl)-2-methyl-1,6-dioxohexan-3-ylidene]amino]-2-hydroxynaphthalene-1-carboxamide 9555801 NSC630357 resistant
hsa-miR-452-5p N-[2-(3,4-dihydroxyphenyl)ethyl]-3-phenylpropanamide 383148 NSC671189 sensitive
hsa-miR-452-5p N-[2-(4-acetylpiperazin-1-yl)ethyl]-3-(3-chloro-5-hydroxyphenyl)-4-pyridin-4-ylpyrazole-1-carboxamide 53483672 NSC753193 sensitive
hsa-miR-452-5p N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(4-pyridin-2-ylpiperazin-1-yl)acetamide 24206025 NSC737733 sensitive
hsa-miR-452-5p N-[6'-(diethylamino)-3-oxospiro[2-benzofuran-1,9'-xanthene]-2'-yl]-N-phenylacetamide 389678 NSC686130 sensitive
hsa-miR-452-5p N,n-bis(2-chloroethyl)-4-(6-chloropurin-9-yl)aniline 254234 NSC78298 resistant
hsa-miR-452-5p NSC605607 NSC605607 sensitive
hsa-miR-452-5p Pc 287 239486 NSC44580 sensitive
hsa-miR-452-5p Pectenotoxin ii 5468320 NSC668555 sensitive
hsa-miR-452-5p Platinum, (1,2-cyclohexanediamine-n,n')(propanedioato(2-)-o,o')-, (sp-4-2-(1r-trans))- (9ci) NSC266047 sensitive
hsa-miR-452-5p Propyl gallate 4947 NSC2626 resistant
hsa-miR-452-5p Protein: pahiv4 NSC678525 sensitive
hsa-miR-452-5p Psoralen quinone 68083 NSC401268 resistant
hsa-miR-452-5p Spiro[s-indacene-2(5h),2'-[2h]inden]-5-one, 1,1',3,3',6,7-hexahydro- 382726 NSC670404 sensitive
hsa-miR-452-5p Stk673166 NSC717468 sensitive
hsa-miR-452-5p Vancide 26 79411 NSC5337 sensitive
hsa-miR-452-5p Ver a 5351232 NSC126728 sensitive
hsa-miR-452-5p Z198955462 135528004 NSC744178 sensitive
hsa-miR-452-5p Z28714792 2671841 NSC746248 sensitive
hsa-miR-452-5p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-452-5p 10-Hydroxycamptothecin 97226 NSC107124 resistant High Gastric Cancer cell line (BGC823, SGC-7901, MGC-803, HGC-27, NCI-N87, AGS)
hsa-miR-452-5p Gemcitabine 60750 NSC613327 approved resistant High Cholangiocarcinoma cell line (HuCCT1, HuH28)
hsa-miR-452-5p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer cell line (MCF-7)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (C13*, A2780, OV2008)
hsa-miR-452-5p Paclitaxel 36314 NSC125973 approved sensitive High Gastric Cancer cell line (BGC823, HGC-27, NCI-N87)
hsa-miR-452-5p Doxorubicin 31703 NSC123127 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-452-5p Docetaxel 148124 NSC628503 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-452-5p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-452-5p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-452-5p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved sensitive High Small Cell Lung Cancer cell line (H446)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer tissue
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved resistant High Gallbladder Cancer cell line (GBC-SD, NOZ)
hsa-miR-452-5p Gefitinib 123631 NSC715055 approved sensitive High Non-Small Cell Lung Cancer cell line (HCC827)
hsa-miR-452-5p Methotrexate 126941 NSC740 approved sensitive High Colorectal Cancer cell line (LS174T)
hsa-miR-452-5p Sunitinib 5329102 NSC750690 approved sensitive High Renal Cell Cancer tissue
hsa-miR-452-5p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (AsPC-1)
hsa-miR-452-5p Bromocriptine 31101 NSC169774 approved resistant High Prolactinoma tissue
hsa-miR-452-5p Fluorouracil 3385 NSC19893 approved sensitive High Colorectal Cancer cell line (HCT-116)
hsa-miR-452-5p Methotrexate 126941 NSC740 approved sensitive High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-452-5p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (A172)
hsa-miR-452-5p Temozolomide 5394 NSC362856 approved resistant cell line (U251)
hsa-miR-452-5p Gefitinib 123631 NSC715055 approved resistant cell line (PC9)
hsa-miR-452-5p Osimertinib 71496458 NSC779217 approved resistant cell line (PC9)
hsa-miR-452-5p Fluorouracil 3385 NSC19893 approved sensitive cell line (HCT116)
hsa-miR-452-5p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-452-5p Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-452-5p Exemestane 60198 NSC713563 approved sensitive cell line (MCF-7)
hsa-miR-452-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-452-5p Fluorouracil 3385 NSC19893 approved sensitive cell line (HCT15)
hsa-miR-452-5p 4-Hydroxytamoxifen+Tamoxifen resistant cell line (LY2)
hsa-miR-452-5p Methotrexate 126941 NSC740 approved sensitive cell line (HT29)
hsa-miR-452-5p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-452-5p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-452-5p Gemcitabine 60750 NSC613327 approved resistant cell line (HuH28)
hsa-miR-452-5p Oxaliplatin 6857599 NSC266046 approved resistant cell line (IGROV-1)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved resistant cell line (IGROV-1)
hsa-miR-452-5p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-452-5p Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved resistant cell line (OVCAR3)
hsa-miR-452-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (H460)
hsa-miR-452-5p Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine resistant cell line (Bats-72)

Error report submission